Overview
Progressive rubella panencephalitis (PRP) is a rare, chronic neurological disorder characterized by progressive dementia, spasticity, ataxia, intellectual deterioration, and seizures, typically developing years after congenital rubella infection 12.Diagnosis
Clinical Presentation: Progressive dementia, spasticity, cerebellar dysfunction, intellectual decline, and seizures 12.
Laboratory Tests: Elevated serum and cerebrospinal fluid (CSF) rubella antibody titers 2.
CSF Analysis: Increased CSF protein and gamma globulin levels 2.
Imaging: Brain MRI may show widespread, progressive subacute panencephalitis affecting white matter 2.
Virological Testing: Attempts to isolate rubella virus from brain and body fluids are often unsuccessful 2.Management
No Specific Treatment: Currently, no definitive antiviral or immunomodulatory treatment is established 12.
Supportive Care: Focus on managing symptoms including anticonvulsants for seizures, physical therapy for motor deficits, and supportive care for cognitive decline 12.Special Populations
Congenital Rubella: Neurological deficits are typically stable post-infancy; late-onset progressive neurologic illness is rare but reported in adolescents 2.Key Recommendations
Consider PRP in adolescents with progressive dementia and associated neurological deficits following congenital rubella infection (Evidence: Moderate) 2.
Evaluate elevated rubella antibody titers in serum and CSF for diagnostic confirmation (Evidence: Moderate) 2.
Implement supportive care measures tailored to symptom management without specific antiviral therapy (Evidence: Expert opinion) 12.References
1 Wolinsky JS, Berg BO, Maitalnd CH. Progressive rubella panencephalitis. Archives of neurology 1976. link
2 Townsend JJ, Baringer JR, Wolinsky JS, Malamud N, Mednick JP, Panitch HS et al.. Progressive rubella panencephalitis. Late onset after congenital rubella. The New England journal of medicine 1975. link